Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:49 AM UTC
| NCT Number | NCT06892548 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 594 participants |
| Active Locations | 17 sites in the US |
| Sponsor | BioNTech SE |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 15, 2026: Clinical trial NCT06892548 is currently recruiting participants. This phase1 study for lung cancer is actively seeking new participants at 17 locations across the United States. The study is sponsored by BioNTech SE. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06892548 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06892548 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.